This is a preview and has not been published. View submission

COMPARISON OF SARS-COV-2 RNA CONCENTRATION AND PURITY VALUES IN NASOPHARYNGEAL SWAB WITH GARGLE SALIVA

Concentration Gargle saliva Nasopharyngeal swab Purity SARS-CoV-2

Authors

Background: The sample employed as the gold standard for diagnosing COVID-19 is the nasopharyngeal swab. Nevertheless, patients typically experience discomfort during sampling and face various risks. Therefore, alternative methods that are less risky and more comfortable for patients, such as gargle saliva, are required. Purpose: This research aims to compare the concentration and purity of SARS-CoV-2 RNA in nasopharyngeal swabs in comparison to gargle saliva. Method: This study employs a descriptive comparative design with a post-only approach. Nasopharyngeal swabs and gargle saliva samples were collected from participants confirmed to have COVID-19 in the vicinity of Bandung and Cimahi City. The samples were then processed using the magnetic beads method, with each sample type replicated four times. The concentration and purity of RNA were assessed using a NanoDrop spectrophotometer. The obtained measurement data were averaged and subsequently subjected to comparison. Result: The average concentration values for nasopharyngeal swab Samples 1, 2, and 3 are 10.95 ng/μL, 7.98 ng/μL, and 7.18 ng/μL, respectively. Correspondingly, the average purity values for these samples are 1.07, 1.23, and 1.21 for gargle saliva, the average purity values for Samples 1, 2, and 3 are 21.1 ng/μL, 6.7 ng/μL, and 8.4 ng/μL, respectively. The mean purity values for these samples are 0.88, 1.24, and 1.17. Conclusion: The concentration of gargle saliva surpasses that of the nasopharyngeal swab, while the purity of the nasopharyngeal swab exceeds that of the gargle saliva.